Table 1 Patient and disease characteristics at baseline
Patient characteristics | Patients (n = 33) | |
|---|---|---|
No. | % | |
Age | 59 years | |
Median (range) | (35–68) | |
PS (ECOG) | ||
Median (range) | 0 (0–1) | |
Menopausal status | ||
Pre | 6 | 18.2 |
Post | 27 | 81.8 |
Stage | ||
Locally advanced | 7 | 21.2 |
Metastatic: | ||
1 site | 9* | 27.3 |
≥ 1 site | 17 | 51.5 |
Site | ||
Breast | 12 | 36.4 |
Bone | 20 | 60.6 |
Liver | 12* | 36.4 |
Lung | 8 | 24.2 |
Lymph nodes | 4 | 12.1 |
Receptor status | ||
ER+ | 22 | 66.7 |
ER- | 8 | 24.2 |
Unknown | 3 | 9.1 |
Prior therapy | ||
None | 16 | 48.5 |
Adjuvant hormonal therapy | 4 | 12.1 |
Adjuvant chemotherapy | 7 | 21.2 |
Chemo- and hormone adjuvant therapy | 4 | 12.1 |
Hormone therapy for advanced disease | 6 | 18.2 |